[
    [
        {
            "time": "",
            "original_text": "1月金股来了！10股获多家券商一致推荐，21股业绩翻倍，最猛增长超2000%，多只低估值绩优股在列（附股）",
            "features": {
                "keywords": [
                    "金股",
                    "券商推荐",
                    "业绩翻倍",
                    "增长超2000%",
                    "低估值绩优股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "股票市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "1月金股来了！10股获多家券商一致推荐，21股业绩翻倍，最猛增长超2000%，多只低估值绩优股在列（附股）",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫情影响逐渐消退，关注高成长龙头+细分冠军——医药生物上市公司2020年三季报小结",
            "features": {
                "keywords": [
                    "疫情",
                    "高成长龙头",
                    "细分冠军",
                    "医药生物",
                    "三季报"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫情影响逐渐消退，关注高成长龙头+细分冠军——医药生物上市公司2020年三季报小结",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|三季报】医疗器械、服务：中国制造优势体现，推荐龙头",
            "features": {
                "keywords": [
                    "浙商医药",
                    "三季报",
                    "医疗器械",
                    "服务",
                    "中国制造",
                    "龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商医药|三季报】医疗器械、服务：中国制造优势体现，推荐龙头",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]